Danone Shares Fall as China Slowdown Overshadows Sales Beat

Shares in Danone (DANO) fell on Wednesday after the French food group reported a slowdown in its crucial China market that overshadowed a second-quarter sales beat, prompting investor concern over the outlook for its high-margin nutrition business.

A Beat with a Catch

Danone reported its first-half 2026 results before the market open in Paris, posting second-quarter organic sales growth of 4.2%, which exceeded the analyst consensus forecast of 3.7%. The company generated quarterly revenues of approximately €7.2 billion, with the like-for-like growth composed of a 2.3% contribution from price and 1.9% from volume.

Despite the headline beat, investors focused on deteriorating momentum in China and North Asia. The slowdown directly impacts Danone's specialized nutrition unit, which includes infant formula and is one of the company's most profitable segments.

China Headwinds and Analyst Sentiment

Ad

The primary concern for the market is the structural challenge posed by declining birth rates in China, a trend analysts have identified as a significant, multi-year risk to earnings for the infant nutrition business. This regional weakness proved to be the decisive factor in the day's trading, leading to a sharp sell-off in the company's shares.

Market sentiment was already cautious heading into the report. Key factors included:

• A recent downgrade from Jefferies to "Underperform," which cited slowing momentum in China and market share losses in the North American yogurt category.
• A contrasting "Buy" rating from Goldman Sachs, which was not enough to counter the bearish sentiment.

The stock fell as much as 3.7% during the session, trading toward a low of €69.32. Broader market indices, such as the CAC 40 in Paris, were largely flat, indicating the decline was driven entirely by company-specific factors.